Suchergebnisse - "*Ritonavir"

PubPharm (9.304)

91

Effect of Hepatic Impairment on the Pharmacokinetics of Nirmatrelvir/Ritonavir, the First Oral Protease Inhibitor for the Treatment of COVID-19

enthalten in: Journal of clinical pharmacology | 2024

von Singh, R. | LaBadie, R. | Toussi, S. | +4

92

Case report : Paralytic ileus resulted from nirmatrelvir/ritonavir-tacrolimus drug-drug interaction in a systemic lupus erythematosus patient with COVID-19

enthalten in: Frontiers in pharmacology | 2024

von Zhang, W. | Zhang, X. | Han, J. | +9

93

Effect of pre-hospitalization use of oral antiviral agents on reducing critical illness and mortality for patients with COVID-19 pneumonia

enthalten in: International journal of antimicrobial agents | 2024

von Yii, Y. | Shih, H. | Chen, C. | +5

94

The effectiveness of oral anti-SARS-CoV-2 agents in non-hospitalized COVID-19 patients with nonalcoholic fatty liver disease : a retrospective study

enthalten in: Frontiers in pharmacology | 2024

von Yang, C. | Tsai, Y. | Wang, S. | +7

95

In outpatients with COVID-19 during Omicron variant circulation, molnupiravir and nirmatrelvir-ritonavir improved outcomes

enthalten in: Annals of internal medicine | 2024

von Chagla, Z.

CommentOn: Ann Intern Med. 2023 Oct;176(10):1377-1385. - PMID 37722115

96

Elucidation of Molecular Interactions Between Drug-Polymer in Amorphous Solid Dispersion by a Computational Approach Using Molecular Dynamics Simulations

enthalten in: Advances and applications in bioinformatics and chemistry : AABC | 2024

von Aulifa, D. | Al Shofwan, A. | Megantara, S. | +2

97

Nirmatrelvir/ritonavir and remdesivir against symptomatic treatment in high-risk COVID-19 outpatients to prevent hospitalization or death during the Omicron era : a propensity score-matched study

enthalten in: Therapeutic advances in infectious disease | 2024

von Rajme-López, S. | Martinez-Guerra, B. | Román-Montes, C. | +13

98

Coadministration of ABCB1/P-glycoprotein inhibitor elacridar improves tissue distribution of ritonavir-boosted oral cabazitaxel in mice

enthalten in: International journal of pharmaceutics | 2024

von Loos, N. | Martins, M. | de Jong, D. | +4

99

Antiviral therapy of coronavirus disease 2019 (COVID-19)

enthalten in: Journal of the Formosan Medical Association = Taiwan yi zhi | 2024

von Chen, P. | Wang, J. | Chang, S.

100

Prescribing of antivirals for COVID-19 in a South Australian local health network according to statewide guidelines

enthalten in: Internal medicine journal | 2024

von Al Naji, H. | Inglis, J. | Tucker, E. | +5